RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma
Clinical trial NCT04176380 · COMPLETED
Trial details
- NCT number
- NCT04176380
- Sponsor
- Rapa Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2023-01-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.